Davenport & CO LLC Reata Pharmaceuticals Inc Transaction History

Davenport & CO LLC

  • $16.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 28, 2019
SELL
$48.76 - $76.44 $554,059 - $868,587
-11,363 Closed
0 $0
Q3 2018

Oct 11, 2018
SELL
$35.64 - $92.06 $35,640 - $92,060
-1,000 Reduced 8.09%
11,363 $929,000
Q1 2018

Apr 04, 2018
BUY
$20.0 - $30.19 $20,000 - $30,190
1,000 Added 8.8%
12,363 $254 Million
Q3 2017

Oct 12, 2017
BUY
$26.29 - $31.88 $298,733 - $362,252
11,363
11,363 $353 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Davenport & CO LLC Portfolio

Follow Davenport & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email